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Abstract   
Herein, we report the synthesis of various heterocyclic ring systems containing 
 
1,2,3-triazole from the reactions of acid hydrazides and commercially available 
 
reagents, using efficient and simple procedures. Reactions of certain 1,2,3-triazole-
4-carbohydrazides and α-bromoketones in boiling ethanol afforded the 
corresponding hydrazones rather than the expected triazines. The hydrazones 
 
could also be synthesized in 85-90% yield via an alternative pathway that 
 
involved  the  reaction of 1,2,3-triazole-4-carbohydrazides and  4-acetyl-1,- 
 
2,3-triazoles in boiling ethanol containing glacial acetic acid. Reaction of one of 
 
the 4-carbohydrazides with carbon disulfide, followed by the reaction with 
 
hydrazine hydrate, gave 4H-1,2,4-triazole-3-thiol in 73% yield, which further 
reacted with other α-bromoketones in boiling ethanol to afford 7H-[1,2,4] 
triazolo[3,4-b][1,3,4]thiadiazines in 82-84% yields. Additionally, reactions of 
 
certain carbohydrazides with ethyl 2-cyano-3,3-bis(methylthio)acrylate gave 
 





1 | INTRODUCTION 
 
Designing novel heterocycles is one of the main chal-lenges 
faced by chemists in the recent years. Many effi-cient 
methodologies have been developed to overcome some of 
the limitations associated with the traditional processes for 
the synthesis of heterocycles that have applications in 
pharmaceutical and other industries.[1,2] Considerable 
efforts have been directed toward the syn-thesis of 
heterocycles using efficient, convenient, high yielding, cost-
effective, and clean methods that involve few reaction steps. 




preservatives and as reagents for determining certain flavo-
noids and also for the production of pharmaceuticals and 
polymers.[3,4] Indeed, acid hydrazides are efficient and com-
mon precursors in the production of various heterocycles[5–8] 
that have enormous potential as antimicrobials,[9–16] anti- 
cancer agents,[17] pharmaceuticals,[18]  
antidepressant,[20] and anti-inflammatory 
agents.[21] In addi-tion, these heterocycles 
act as herbicides[22] and dyes.[23,24]  
Acid hydrazides are generally produced from reaction of 
hydrazine and esters, cyclic anhydrides, acyl halides, and 
aldehydes,[25] while [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines 
can be produced through a two-step reaction that involves   




hydrazides, carbon disulfide, hydrazine hydrate, and phen-
acyl bromides.[26–28]  
Heterocycles such as 1,2,3-triazoles have potentially 
important applications, and various processes have been 
developed for their synthesis.[29–34] Recently, we have 
reported several procedures for the synthesis of various 
heterocycles.[35–40] Herein, we report efficient and simple 
methods for the synthesis of heterocycles containing the 
1,2,3-triazole moieties. These heterocycles, synthesized 
from 1,2,3-triazole-4-carbohydrazides, have important 
applications in many fields. 
 
 
2 | RESULTS AND DISCUSSION 
 
Reactions of carbohydrazides 1a-d (X = H, Me, Br, Cl)  
and 2-bromo-1-(5-methyl-1-aryl-1H-1,2,3-triazol-4-yl) 
ethanones 2a,b (Y = Br, Cl) in boiling ethanol for 12 hours 
in the presence of sodium acetate and glacial acetic acid 
afforded hydrazones 3a-f (Scheme 1) in 46-58% yields 
(Table 1). No evidence was found for the expected products 
1,2,4-triazines (4) under these condi-tions. The infrared (IR) 
spectra of 3a-f showed strong absorption bands 
corresponding to carbonyl stretching at 1679-1785 cm−1. 
The 1H NMR spectra of 3a-f showed exchangeable singlets 
at 10.19-10.28 ppm due to the pres-ence of NH protons. In 
addition, the 1H NMR spectra showed three singlets for the 
three different methyl groups in 3a,c-f and four singlets 
corresponding to the four different methyl groups in 3b 
(1.54-2.70 ppm). The 13C NMR spectra of 3a-f suggested 
the presence of car-bonyl carbons, as indicated by the 
chemical shift at about 157 ppm, along with all the other 
expected carbon atoms.  
The molecular structures of 3a, 3b, and 3f obtained by 
X-ray diffraction are shown in Figure 1. The ethylidene-
formohydrazide group at the center of the molecule is 
essentially planar in all the three compounds. 
 
For 3a, the twist angle between the neighboring bromo-
phenyl and methyltriazolyl groups is 45.1(1) , and the angle 
between the phenyl group and the second methyltriazolyl 
group is 41.9(1) . The corresponding angles in 3b are 
43.5(1) and 40.0(1) , respectively. Com-pound 3f has two 
chlorophenyl groups and two triazolyl groups. The two 
twist angles between the groups are sim-ilar [50.1(1) and 
49.9(1) ].  
It has been reported that reaction of bromoacetyl arenes 
and pyridine-2-carboxylic acid hydrazide or 2-
thienylcarboxylic acid hydrazide gave the corresponding 3-
pyridyl-1,2,4-triazines or 3-thienyl-1,2,4-triazines in low to 
moderate yields under similar reaction conditions to those 
used in Scheme 1.[41] Clearly, different acid hydra-zides 
were used, and this could be the reason for the for-mation of 
different products.  
Formation of 3 involves reaction of hydrazides 1 and 
bromides 2 to produce the corresponding bromohydrazones 
A. Replacement of bromide of A in the presence of sodium 
acetate, which acts as a catalyst, gave intermediate B. It has 
been reported that debromination of α-bromoketones took 
place in the presence of acetic acid and sodium iodide.[42] 
Treatment of B with acetic acid gave the corresponding 




T A B L E 1 Melting point and yield of Compounds 3 
synthesized according to Scheme 1 
 
 Product X Y Melting point ( C) Yield (%)  
 3a H Br 248-250 46  
       
 3b Me Br 258-260 49  
 3c H Cl 246-248 51  
       
 3d Br Br 259-260 54  
 3e Br Cl 260-262 52  
       
 3f Cl Cl 244-246 58  
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S C H E M E 1 Synthesis of hydrazones 3 
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Compounds 3 could also be produced in 79-87% yields 
via an alternative synthetic pathway wherein hydrazides 1 
reacted with 4-acetyl-1,2,3-triazoles 5 to give hydrazides 3 
(Scheme 3). The products were identical to those pro-duced 
in the reactions shown in Scheme 1.  
Reaction of 1c (X = Br) and excess carbon disulfide 
















































F I G U R E 1 ORTEP representation of the molecular structure of 
3a, 3b, and 3f with 50% probability ellipsoids obtained by X-ray 
diffraction  
 
ethoxide at 0 C for 2 hours, followed by the treatment with 
excess hydrazine hydrate (two molar equivalents) under 
reflux for 5 hours, gave 4H-1,2,4-triazole-3-thiol 6 in 73% 
yield (Scheme 4). The 1H NMR spectrum of 6 showed 
exchangeable singlets at 5.92 (2H) and 14.07 ppm (1H) due 
to the NH2 and SH protons, respec-tively. Reactions of 6 
and α-bromoketones 7a-c in boiling ethanol in the presence 
of triethylamine as a base for 2 hours gave the 
corresponding 7H-[1,2,4]triazolo[3,4-b] [1,3,4]thiadiazines 
8a-c in 74-82% yields (Scheme 4).  
The molecular structures of 8a and 8c obtained by X-ray 
diffraction are shown in Figure 2. In both 8a and 8c, the 
triazolothiadiazine groups are almost planar, while the 
methylene group deviates from planarity. The twist angles 
between the bromophenyl and methyltriazolyl groups are 
40.4(1) and 47.4(1) for 8a and 8c, respectively.  
Finally, the reaction of acid hydrazides 1c,d and ethyl 2-
cyano-3,3-bis (methylthio)acrylate (9) in boiling ethanol for 
3 hours gave the corresponding 1-aryl-1H-,-2,3-triazole-4-
carbohydrazides 10a,b (Scheme 5) in 55% (X = Cl) and 
56% (X = Br) yields. None of the expected products, 1H-
pyrazole-4-carboxylates 11a,b, were formed under these 
conditions. Compounds 10a,b have been syn-thesized 
previously from the reaction of acid hydrazides 1c,d and 2-
(methoxymethylene)malononitrile or ethyl 2-cyano-3-
methoxyacrylate in boiling ethanol.[24]  
The structures of 10a and 10b obtained by X-ray dif-
fraction are shown in Figure 3. In both 10a and 10b, the two 
halves of the molecule are related by pseudo-twofold 
symmetry through the hydrazine bond, with the formyl 
formohydrazide groups in gauche conformation. The twist 
angles between the bromophenyl and triazolyl groups are 
38.0(1) and 46.9(1) for 10a and 35.5(1) and 48.4(1) between 
chlorophenyl and triazolyl groups for 10b.  
The formation of 10 involves the nucleophilic attack of 
NH2 of the second mole of hydrazide 1 at the carbonyl 
carbon of intermediate 12, which is formed from the 
reaction of 1 and 9, to produce intermediate 13. 
Diacylhydrazines 10 along with 9 were produced from the 
dissociation of 13 (Scheme 6). 
 
 
3 | CONCLUSION 
 
In summary, simple methods have been developed for the 
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of acid hydrazides containing the 1,2,3-triazole moiety and 
α-bromoketones gave the corresponding hydrazones rather 
than the expected 1,2,4-triazines, while reaction of acid 
hydrazides and carbon disulfide followed by hydra-zine 
hydrate gave the corresponding 1,2,4-triazole-3-thiol which 
on reaction with α-bromoketones gave the corresponding 
7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines. In addition, 
reaction of acid hydrazides and ethyl 2-cyano-3,3-bis 
(methylthio)acrylate gave the corresponding (1,2,3-triazole-
4-carbonyl)-1,2,3-triazole-4-carbohydrazides rather than the 
expected 1H-pyrazole-4-carboxylates. These compounds are 
expected to have important applica-tions in many fields. 
 
 
Single-crystal X-ray diffraction data were collected on 
an Agilent SuperNova Dual Atlas diffractometer with a 
mirror monochromator using either Cu (λ = 1.5418 Å) or 
Mo (λ = 0.7107 Å) radiation. Crystal structures were solved 
using SHELXS[43] and refined using SHELXL.[44] 
Nonhydrogen atoms were refined with anisotropic dis-
placement parameters. Hydrogen atoms were inserted in 
idealized positions, and a riding model was used with 
Uiso(H) set at 1.2 or 1.5 times the value of Ueq(C/N). The 
crystallographic data for compounds 3a, 3b, 3f, 8a, 8c, 10a, 
and 10b have been deposited at the Cambridge Crys-




4 | EXPERIMENTAL 
 
An Electrothermal IA 9000 melting point apparatus was 
used to determine the melting points. Elemental analyses 
were performed at Cairo University, Egypt. The IR spec-tra 
were recorded on a JASCO FT/IR-6100 spectrometer using 
KBr disks. A JOEL-ECA 600 MHz spectrometer was used 
to record the NMR spectra at 600 MHz for 1H and 150 MHz 
for 13C NMR in deuterated dimethyl sulfox-ide using 
tetramethylsilane as the internal standard. 
 
 
4.1 | Synthesis 
 
Compounds 1,[19–21] 2,[45] 5,[46] 7,[47] and 9[48] were syn-
thesized using the procedures reported in literature.  
Synthesis of 5-methyl-N0 -(1-(5-methyl-1-aryl-1H-1,-
2,3-triazol-4-yl)ethylidene)-1-aryl-1H-1,2,3-triazole-  
4-carbohydrazides 3: Method A. A mixture of 1 (2.0 mmol) 
and 2 (2.0 mmol) in EtOH (20 mL) containing glacial 
AcOH (2 mL) and MeCO2Na.3H2O (0.27 g, 2.0 mmol) was 
refluxed for 5 hours. The solid obtained on cooling 
   5 
 
was filtered and recrystallized from EtOH. Pure com-pound 
3 was obtained in 46-58% yields (Table 1).  
Synthesis of 3a-f: Method B: A mixture of 1 (2.0 mmol), 5
(2.0 mmol), and glacial acetic acid (2 mL) in EtOH  
 
(20 mL) was refluxed for 5 hours. The solid obtained on 
cooling was filtered and recrystallized from EtOH. Pure 
products were obtained in 79-85% yields.  
N0-(1-(1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-
yl)ethylidene)-5-methyl-1-phenyl-1H-1,2,3-triazole-4-


































F I G U R E 2  ORTEP representation of the molecular structures F I G U R E 3  ORTEP representation of the molecular structure 
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1H NMR: δ 1.56 (s, 3H, CH3), 2.64 (s, 3H, CH3), 2.70 1H NMR: δ 1.54 (s, 3H, CH3), 2.64 (s, 3H, CH3), 2.68 
(s, 3H, CH3), 7.54-7.70 (m, 9H, Ar), 10.22 (s, exch., 1H, (s, 3H, CH3), 7.51-7.73 (m, 8H, Ar), 10.28 (s, exch., 1H, 
NH). 13C NMR: δ 9.8, 11.2, 13.0, 123.8, 125.2, 126.8, NH). 13C NMR: 9.7, 11.2, 14.9, 123.5, 128.4, 128.6, 129.8, 
129.7, 130.2, 132.8, 133.5, 134.9, 135.4, 137.6, 137.9, 130.2, 133.6, 134.9, 135.0, 135.2, 135.9, 139.3, 139.6, 145.6, 
142.97,  148.0,  157.2.  Anal.  Calcd.  for  C21H19BrN8O 157.6.  Anal.  Calcd.  for  C21H18BrClN8O  (512.05):  C, 
(478.09):  C, 52.62; H,  4.00;  N, 23.38%.  Found:  C, 49.09; H, 3.53; N,  21.81%. Found: C, 49.23; H, 
52.47; H, 4.19; N, 23.68%.          3.65; N, 22.01%.          
N0-(1-(1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazol- 1-(4-Chlorophenyl)-N0-(1-(1-(4-chlorophenyl)-5-methyl- 
4-yl)ethylidene)-5-methyl-1-(4-tolyl)-1H-1,2,3-triazole- 1H-1,2,3-triazol-4-yl)ethylidene)-5-methyl-1H-1,2,3-triazole- 
4-carbohydrazide (3b): IR (KBr) νmax/cm−1: 1681 (C      O). 4-carbohydrazide (3f) : IR (KBr) νmax/cm−1: 1680 (C   O).             
1H NMR: δ 1.55 (s, 3H, CH3), 2.46 (s, 3H, CH3), 2.64 (s, 1H NMR: δ 1.61 (s, 3H, CH3), 2.46 (s, 3H, CH3), 2.49 (s, 
3H, CH3), 2.70 (s, 3H, CH3), 7.51-7.70 (m, 8H, Ar), 10.21 3H, CH3), 7.52-7.59 (m, 8H, Ar), 10.88 (s, exch., 1H, NH). 
(s, exch., 1H, NH). 13C NMR: 9.8, 11.2, 15.0, 21.3, 123.8, 13C NMR: 9.9, 10.1, 14.9, 128.1, 128.9, 129.5, 131.7, 133.7, 
125.1, 128.8, 129.0, 131.3, 132.8, 134.5, 135.0, 135.5, 138.6, 133.9, 134.2, 134.7, 135.0, 135.5, 139.3, 139.5, 145.6, 157.6. 
139.1, 139.7, 146.5, 157.3. Anal. Calcd. for C22H21BrN8O Anal. Calcd. for C21H18Cl2N8O (468.10): C, 53.74; H, 
(492.10): C, 53.56; H, 4.29; N, 22.71%. Found: C, 53.75; H, 3.87; N, 23.88; Found: C, 53.86; H, 23.99; N, 23.65%   
4.37; N, 22.96%.           Synthesis  of  4-amino-5-(1-(4-bromophenyl)-5-methyl- 
N0-(1-(1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazol- 1H-1,2,3-triazol-4-yl)-4H-1,2,4-triazole-3-thiol (6): A mix- 
4-yl )ethylidene)-5-methyl-1-phenyl-1H-1,2,3-triazole- ture of 1c (1.50 g, 5.0 mmol), CS2 (0.70 g, 10.0 mmol), 
4-carbohydrazide (3c): IR (KBr) νmax/cm−1: 1679 (C      O). and KOH (0.12 g, 2.0 mmol) in aqueous EtOH (20 mL,         
1H NMR: δ 1.58 (s, 3H, CH3), 2.67 (s, 3H, CH3), 2.70 80%) was stirred for 2 hours at 0-5 C in an ice bath. 
(s, 3H, CH3), 7.46-7.61 (m, 9H, Ar), 10.24 (s, exch., 1H, Hydrazine hydrate (0.20 g, 4.0 mmol) was added, and the 
NH). 13C NMR: 9.8, 11.2, 15.1, 125.0, 128.2, 128.5, 129.5, reaction mixture was refluxed for 5 hours. The mixture 
129.8, 134.2, 134.6, 135.4, 135.6, 135.8, 139.6, 139.9, 148.0, was allowed to cool to room temperature and poured into 
157.2. Anal. Calcd. for C21H19ClN8O (434.14): C, 58.00; H, ice water (200 mL); dilute HCl was added till a pH of 
4.40; N, 25.77%. Found: C, 58.15; H, 4.57; N, 25.88%.          7 was attained. The white solid obtained was collected by 
1-(4-Bromophenyl)-N0-(1-(1-(4-bromophenyl)-5-methyl- filtration to afford pure compound 6. Yield: 73%; Mp: 
1H-1,2,3-triazol-4-yl)ethylidene)-5-methyl-1H-1,2,3-triazole- 260-261 C. IR (KBr) νmax/cm−1: 3321 (NH2). 1H NMR: δ 
4-carbohydrazide (3d): IR (KBr) νmax/cm−1: 1683 (C    O). 2.43 (s, 3H, CH3), 5.92 (s, exch., 2H, NH2), 7.61  (d,       
1H NMR: δ 1.55 (s, 3H, CH3), 2.64 (s, 3H, CH3), 2.70 (s, J = 9.2 Hz, 2H, Ar); 7.68 (d, J= 9.2 Hz, 2H, Ar), 14.07 (s, 
3H, CH3), 7.54-7.73 (m, 8H, Ar), 10.19 (s, exch., 1H, NH). exch., 1H, SH). 13C NMR: 9.9, 123.1, 127.8, 132.1, 133.5, 
13C NMR: 9.8, 11.2, 15.0, 123.2, 123.8, 128.2, 128.6, 131.6, 135.1, 143.6, 145.6, 166.2. Anal. Calcd. for C11H10BrN7S 
132.0, 134.0, 134.8, 135.0, 135.0, 139.3, 139.5, 145.6, 157.6. (350.99): C, 37.51; H, 2.86; N, 27.84%. Found: C, 37.66; H, 
Anal. Calcd. for C21H18Br2N8O (556.00): C, 45.18; H, 2.97; N, 28.07%.          
3.25; N, 20.07%. Found: C, 45.26; H, 3.45; N, 20.19%.          Synthesis of 3-(1-(4-bromophenyl)-5-methyl-1H-1,- 
1-(4-Bromophenyl)-N0-(1-(1-(4-chlorophenyl)-5-methyl- 2,3-triazol-4-yl)-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thia- 
1H-1,2,3-triazol-4-yl)ethylidene)-5-methyl-1H-1,2,3-triazole- diazines  8: A  mixture of  6 (0.35 g, 1.0 mmol) and 
4-carbohydrazide (3e): IR (KBr) νmax/cm−1: 1682 (C 
   
O). α-bromoketones 7 (2.0 mmol) in anhydrous  EtOH 
 
     
 
 
(20 mL) was heated under reflux for 3 hours. The solid 
formed on cooling was filtered, washed with EtOH, and 




Yield: 82%; Mp: 257-259 C. 1H NMR: δ 2.56 (s, 3H, CH3), 
4.55 (s, 2H, CH2), 7.51 (d, J = 9.2 Hz, 2H, Ar), 7.59 (d, J = 
9.2 Hz, 2H, Ar), 7.65-7.82 (m, 5H, Ph). 13C NMR: δ 9.8, 
35.0, 123.5, 125.4, 128.1, 128.6, 131.1, 131.6, 131.9, 133.0, 
134.9, 143.9, 147.2, 154.0, 162.8. Anal. Calcd. for 
C19H14BrN7S (451.02): C, 50.45; H, 3.12; N, 21.68%. 
Found: C, 50.59; H, 3.32; N, 21.73%.  
6-(4-Bromophenyl)-3-(1-(4-bromophenyl)-5-methyl-
1H-1,2,3-triazol-4-yl)-7H-[1,2,4]triazolo[3,4-
b][1,3,4]thiadiazine (8b): Yield: 78%; Mp: 282-283 C. 1H 
NMR: δ 2.53 (s, 3H, CH3), 4.69 (s, 2H, CH2), 7.61 (d, J = 
9.2 Hz, 2H, Ar), 7.66 (d, J = 9.4 Hz, 2H, Ar), 7.72 (d, J =
9.2 Hz, 2H, Ar), 7.78 (d, J = 9.4 Hz, 2H, Ar). Anal. Calcd. 
for C19H13Br2N7S (528.93): C, 42.96; H, 2.47; N, 18.46%. 
Found: C, 43.07; H, 2.88; N, 18.66%.  
6-(Benzofuran-2-yl)-3-(1-(4-bromophenyl)-5-methyl-1H-
1,2,3-triazol-4-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine 
(8c): Yield: 74%; Mp: 267-268 C. 1H NMR: δ 2.53 (s, 3H, 
CH3), 4.56 (s, 2H, CH2), 6.90 (s, 1H, furyl), 7.58 (d, J = 9.4 
Hz, 2H, Ar), 7.64 (d, J = 9.4 Hz, 2H, Ar), 7.69-7.84 (m, 4H, 
Ar). 13C NMR: δ 10.0, 32.9, 112.4, 114.8, 123.3, 123.7, 124.6, 
127.7, 127.8, 128.5, 132.8, 133.3, 135.3, 136.2,  
143.1, 146.3, 147.2, 149.1, 156.0. Anal. Calcd. for 
C21H14BrN7OS (491.02): C, 51.23; H, 2.87; N, 19.91%. 
Found: C, 51.46; H, 2.97; N, 20.21%.  
Synthesis of 5-methyl-N0-(5-methyl-1-aryl-1H-1,2,3-tri-
azole-4-carbonyl)-1-aryl-1H-1,2,3-triazole-4-carbohydrazi-
des 10: A mixture of 1c,d (3.0 mmol) and 9 (0.65 g, 3.0 
mmol) in anhydrous EtOH (20 mL) was refluxed for 3 h. 
The solid obtained on cooling was filtered, washed with 
EtOH, and dried. Pure compounds 10a and 10b were 
obtained in 55 and 56% yields, respectively. The analytical 
and spectral data for the products were in agreement with 
those reported previously.[29] 
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